NCT03722121

Brief Summary

This project has for objective to demonstrate that the increase of the distance "Patient home - center of treatment" may be associated with significant, other noticeable, noted events. This distance may also be available in the Rouen University Hospital. The study of the association in this distance and the delay in initiating chemotherapy after surgery in patients treated at the CHU correspond to a pilot study prior to the completion of the analysis at the regional scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2017

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2018

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 26, 2018

Completed
Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

October 27, 2017

Last Update Submit

April 22, 2026

Conditions

Keywords

distance

Outcome Measures

Primary Outcomes (1)

  • distance "home of patients - treatment center"

    Analyze the influence of distance "home of patients - treatment center" on the compliance of the time between colectomy and initiation of CTa

    At the inclusion

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient having a cancer colon and hospitalized for colectomy: malignant tumor colon, in situ colon carcinoma or tumor with unpredictable or unknown evolution of the colon

You may qualify if:

  • \- Patients who had colectomy for colon cancer and at least one chemotherapy treatment at CHU Rouen, between 2009 and the first half of 2015.

You may not qualify if:

  • Patients who died in hospital before receiving a chemotherapy treatment
  • Patients with a CIM code of metastasis during the stay of the colectomy or the first chemotherapy treatment
  • Patients who received a chemotherapy treatment before colectomy
  • Patients who have undergone several colectomies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rouen University Hospital

Rouen, 76000, France

Location

Related Publications (1)

  • Conformité du délai d'initiation de la chimiothérapie adjuvante pour cancer du côlon : élaboration d'un indicateur qualité à partir du PMSI - T. Vermeulin1, M. Lucas1, H. Lahbib1, L. Froment1, P. Czernichow1, V. Josset1, F. Jusot2, F. Di Fiore3, G. Launoy4 et V. Merle1* - 10.3166/onco-2018-0014

    BACKGROUND

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2017

First Posted

October 26, 2018

Study Start

March 23, 2017

Primary Completion

January 23, 2018

Study Completion

January 23, 2018

Last Updated

April 27, 2026

Record last verified: 2026-04

Locations